AliveCor QT Service vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Viz.ai

AI Verdict

AliveCor QT Service is designed for assessing cardiac safety by providing instant QT and QTc interval measurements from specific ambulatory ECG devices, primarily to inform medication prescribing decisions. In contrast, Viz HCM is an AI tool specifically for detecting suspected Hypertrophic Cardiomyopathy from real-time ECG analysis within hospital systems and coordinating subsequent patient care workflows. While both leverage AI for ECG analysis in cardiology, their distinct clinical objectives and integration points make them suitable for different use cases within cardiac care.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is rapid, precise QT and QTc interval measurement from AliveCor 6-Lead ECGs to assess cardiac safety. This tool is ideal for healthcare professionals who need to inform medication prescribing decisions, especially when monitoring for drug-induced QT prolongation in individual patients.

View AliveCor QT Service →

Choose Viz HCM if…

Choose Viz HCM if your institution requires an AI-powered solution for real-time, system-wide detection of suspected Hypertrophic Cardiomyopathy (HCM) from ECGs. This tool excels at streamlining cardiac care coordination by providing mobile alerts to multidisciplinary teams and automating patient direction to appropriate specialists, significantly reducing diagnosis time for HCM.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service Viz HCM
Pricing Varies by product and service, with subscription options available. Subscription-based
Deployment Mobile app, cloud-based platform, EHR integration. Cloud-based platform, integrated into hospital IT systems (EHR, PACS).
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Viz HCM offers a more comprehensive workflow integration for healthcare professionals, including mobile-based alerts and access to imaging for multidisciplinary care teams within hospital systems. Its platform is designed by engineers who worked on popular apps, aiming for ease of use within complex clinical workflows. While AliveCor QT Service is easy for patient use and immediate QT measurement, Viz HCM's focus on intelligent care coordination across an enterprise gives it an edge in overall usability for healthcare teams.

Clinical Value

Viz HCM

Viz HCM addresses a critical unmet need by providing the first and only FDA-cleared AI algorithm for detecting Hypertrophic Cardiomyopathy (HCM), a condition where nearly 85% of patients are undiagnosed. It has extensive real-world evidence demonstrating consistent performance and a significant reduction in diagnosis time. AliveCor QT Service offers valuable cardiac safety measurements, but Viz HCM's impact on a specific, often missed, and potentially deadly disease is more profound.

Pricing & Value

Viz HCM

Viz HCM is more transparent about its subscription-based pricing model for hospitals and health systems and explicitly mentions CMS reimbursement availability for specific CPT codes, which adds significant financial value for providers. AliveCor QT Service requires contacting the vendor for pricing details, making its cost-effectiveness less clear. The established reimbursement pathway for Viz HCM directly supports its adoption and financial viability in clinical practice.

Enterprise Readiness

Viz HCM

Viz HCM demonstrates superior enterprise readiness through its seamless integration with existing hospital IT systems, including EHR and PACS, and its broader 'Viz.ai One' platform which supports over 50 AI models for system-wide collaboration. It also provides a comprehensive Trust Center with SOC 2 Type II and ISO certifications, ensuring robust security and compliance for large-scale deployments. While AliveCor offers strong integration capabilities, Viz.ai's extensive ecosystem and detailed compliance documentation position it more strongly for enterprise-wide adoption.

Innovation

Viz HCM

Viz HCM's innovation extends beyond mere detection to 'intelligent care coordination,' providing real-time disease detection, mobile alerts, and automated direction of patients to specialists, effectively creating a streamlined care pathway for HCM. This holistic approach to managing a specific, often undiagnosed condition represents a higher degree of innovation in transforming clinical workflows and patient outcomes. AliveCor QT Service's 'InstantQT' is innovative for immediate QT measurement, but Viz HCM's integrated care coordination is a more comprehensive innovation.

Support & Docs

Viz HCM

Viz HCM offers robust customer support, including 24/7 urgent phone support with a guaranteed 15-minute response time, and a comprehensive online Knowledge Base for troubleshooting and documentation. Additionally, its Trust Center provides extensive security and privacy documentation for partners and customers. AliveCor provides standard support channels, but lacks the explicit 24/7 urgent support and the detailed knowledge base/trust center that Viz.ai offers, and some user reviews indicate issues with their customer service.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service Viz HCM
Name AliveCor QT Service Viz HCM
Company AliveCor Viz.ai
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Primary Function Instant, accurate QT interval measurement for enhanced cardiac safety and informed clinical decision-making. AI-powered disease detection and intelligent care coordination for Hypertrophic Cardiomyopathy.
Key Features Cloud-based Software as a Medical Device (SaMD); Measures QT and QTc intervals (Bazett's and Fridericia's formulas); Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L); Prescription (Rx) use only, for qualified healthcare professionals; Utilizes AI and deep neural networks for ECG analysis; Provides instant QT measurements (as InstantQT); Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms. AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection; Real-time disease detection from electrocardiograms; Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Reduces time to diagnosis and treatment for HCM; Streamlines cardiac care coordination and clinical workflows; Seamless integration with existing clinical workflows, EHR, and PACS systems; Clinically validated with extensive real-world evidence and publications.
Target Condition QT and QTc interval measurement for cardiac safety and medication prescribing decisions. Hypertrophic Cardiomyopathy (HCM) detection and care coordination.
ECG Device Compatibility AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L) Analyzes 12-lead ECGs throughout the health system

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and Viz HCM.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs to assess cardiac safety and inform medication prescribing decisions. Viz HCM is an FDA-cleared AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, aiming to reduce diagnosis time.
AliveCor QT Service analyzes ECGs specifically from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. Viz HCM analyzes 12-lead ECGs from across a health system in real-time to identify patterns suggestive of HCM.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. Viz HCM is a cloud-based platform designed for seamless integration with existing clinical workflows, EHR, and PACS systems within hospitals and health systems.
Viz HCM provides mobile-based alerts and notifications to multidisciplinary care teams and automates the direction of patients to appropriate care specialists, streamlining cardiac care coordination. AliveCor QT Service primarily focuses on providing instant QT measurements to inform medication prescribing decisions for cardiac safety.
Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90 effective January 1, 2025. For AliveCor QT Service, physicians need to contact the vendor directly for pricing details.
AliveCor QT Service is for prescription (Rx) use only by qualified healthcare professionals and is intended for use in professional medical facilities. Viz HCM is subscription-based for hospitals and health systems, and is designed to be used by healthcare professionals involved in the care of patients with HCM, including cardiologists and internists.
AliveCor QT Service measures QT and QTc intervals using Bazett's and Fridericia's formulas to assess cardiac safety and the risk of QT prolongation. Viz HCM specifically focuses on the detection of suspected Hypertrophic Cardiomyopathy (HCM) through AI-powered ECG analysis.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.